nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—DRD4—Gilles de la Tourette syndrome	0.286	0.342	CbGaD
Ropinirole—DRD3—Gilles de la Tourette syndrome	0.246	0.295	CbGaD
Ropinirole—DRD2—Gilles de la Tourette syndrome	0.17	0.204	CbGaD
Ropinirole—HTR2A—Gilles de la Tourette syndrome	0.132	0.158	CbGaD
Ropinirole—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00278	0.0781	CbGeAlD
Ropinirole—DRD4—brain—Gilles de la Tourette syndrome	0.00137	0.0385	CbGeAlD
Ropinirole—DRD3—nervous system—Gilles de la Tourette syndrome	0.00126	0.0354	CbGeAlD
Ropinirole—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00121	0.0341	CbGeAlD
Ropinirole—DRD5—nervous system—Gilles de la Tourette syndrome	0.00118	0.0332	CbGeAlD
Ropinirole—DRD5—central nervous system—Gilles de la Tourette syndrome	0.00114	0.0319	CbGeAlD
Ropinirole—DRD1—midbrain—Gilles de la Tourette syndrome	0.0011	0.0308	CbGeAlD
Ropinirole—DRD3—brain—Gilles de la Tourette syndrome	0.000964	0.0271	CbGeAlD
Ropinirole—DRD5—brain—Gilles de la Tourette syndrome	0.000904	0.0254	CbGeAlD
Ropinirole—DRD1—nervous system—Gilles de la Tourette syndrome	0.000903	0.0253	CbGeAlD
Ropinirole—HTR1B—midbrain—Gilles de la Tourette syndrome	0.00089	0.025	CbGeAlD
Ropinirole—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00087	0.0244	CbGeAlD
Ropinirole—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000862	0.0242	CbGeAlD
Ropinirole—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000854	0.0239	CbGeAlD
Ropinirole—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000732	0.0205	CbGeAlD
Ropinirole—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000719	0.0202	CbGeAlD
Ropinirole—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000709	0.0199	CbGeAlD
Ropinirole—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000705	0.0198	CbGeAlD
Ropinirole—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000702	0.0197	CbGeAlD
Ropinirole—DRD1—brain—Gilles de la Tourette syndrome	0.000691	0.0194	CbGeAlD
Ropinirole—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000682	0.0191	CbGeAlD
Ropinirole—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000676	0.019	CbGeAlD
Ropinirole—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000659	0.0185	CbGeAlD
Ropinirole—DRD2—midbrain—Gilles de la Tourette syndrome	0.000649	0.0182	CbGeAlD
Ropinirole—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000635	0.0178	CbGeAlD
Ropinirole—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000631	0.0177	CbGeAlD
Ropinirole—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000591	0.0166	CbGeAlD
Ropinirole—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000569	0.016	CbGeAlD
Ropinirole—HTR1B—brain—Gilles de la Tourette syndrome	0.00056	0.0157	CbGeAlD
Ropinirole—HTR1D—brain—Gilles de la Tourette syndrome	0.000542	0.0152	CbGeAlD
Ropinirole—HTR2C—brain—Gilles de la Tourette syndrome	0.000536	0.015	CbGeAlD
Ropinirole—DRD2—nervous system—Gilles de la Tourette syndrome	0.000534	0.015	CbGeAlD
Ropinirole—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000519	0.0146	CbGeAlD
Ropinirole—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000514	0.0144	CbGeAlD
Ropinirole—HTR2B—brain—Gilles de la Tourette syndrome	0.000504	0.0141	CbGeAlD
Ropinirole—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000504	0.0141	CbGeAlD
Ropinirole—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.0005	0.014	CbGeAlD
Ropinirole—HTR1A—brain—Gilles de la Tourette syndrome	0.000452	0.0127	CbGeAlD
Ropinirole—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000428	0.012	CbGeAlD
Ropinirole—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000414	0.0116	CbGeAlD
Ropinirole—DRD2—brain—Gilles de la Tourette syndrome	0.000408	0.0114	CbGeAlD
Ropinirole—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000399	0.0112	CbGeAlD
Ropinirole—ADRA2C—brain—Gilles de la Tourette syndrome	0.000397	0.0111	CbGeAlD
Ropinirole—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000352	0.00988	CbGeAlD
Ropinirole—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000339	0.00951	CbGeAlD
Ropinirole—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000326	0.00914	CbGeAlD
Ropinirole—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000321	0.009	CbGeAlD
Ropinirole—ADRA2A—brain—Gilles de la Tourette syndrome	0.000316	0.00888	CbGeAlD
Ropinirole—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000314	0.0088	CbGeAlD
Ropinirole—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000309	0.00866	CbGeAlD
Ropinirole—HTR2A—brain—Gilles de la Tourette syndrome	0.000269	0.00755	CbGeAlD
Ropinirole—CYP2D6—brain—Gilles de la Tourette syndrome	0.000245	0.00688	CbGeAlD
Ropinirole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	8.39e-05	0.000643	CbGpPWpGaD
Ropinirole—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	8.37e-05	0.000641	CbGpPWpGaD
Ropinirole—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	8.32e-05	0.000637	CbGpPWpGaD
Ropinirole—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.28e-05	0.000634	CbGpPWpGaD
Ropinirole—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	8.25e-05	0.000632	CbGpPWpGaD
Ropinirole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	8.15e-05	0.000624	CbGpPWpGaD
Ropinirole—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.14e-05	0.000624	CbGpPWpGaD
Ropinirole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.12e-05	0.000622	CbGpPWpGaD
Ropinirole—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.01e-05	0.000613	CbGpPWpGaD
Ropinirole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	7.95e-05	0.000609	CbGpPWpGaD
Ropinirole—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	7.91e-05	0.000606	CbGpPWpGaD
Ropinirole—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.9e-05	0.000605	CbGpPWpGaD
Ropinirole—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.9e-05	0.000605	CbGpPWpGaD
Ropinirole—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.84e-05	0.000601	CbGpPWpGaD
Ropinirole—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.84e-05	0.0006	CbGpPWpGaD
Ropinirole—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.8e-05	0.000598	CbGpPWpGaD
Ropinirole—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	7.75e-05	0.000594	CbGpPWpGaD
Ropinirole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	7.72e-05	0.000591	CbGpPWpGaD
Ropinirole—DRD4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.71e-05	0.000591	CbGpPWpGaD
Ropinirole—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.68e-05	0.000588	CbGpPWpGaD
Ropinirole—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.61e-05	0.000583	CbGpPWpGaD
Ropinirole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.59e-05	0.000581	CbGpPWpGaD
Ropinirole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.49e-05	0.000574	CbGpPWpGaD
Ropinirole—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.45e-05	0.000571	CbGpPWpGaD
Ropinirole—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.45e-05	0.000571	CbGpPWpGaD
Ropinirole—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.39e-05	0.000566	CbGpPWpGaD
Ropinirole—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.38e-05	0.000565	CbGpPWpGaD
Ropinirole—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.36e-05	0.000564	CbGpPWpGaD
Ropinirole—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.36e-05	0.000564	CbGpPWpGaD
Ropinirole—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.36e-05	0.000563	CbGpPWpGaD
Ropinirole—DRD3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.35e-05	0.000563	CbGpPWpGaD
Ropinirole—DRD5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.32e-05	0.000561	CbGpPWpGaD
Ropinirole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.27e-05	0.000557	CbGpPWpGaD
Ropinirole—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.21e-05	0.000552	CbGpPWpGaD
Ropinirole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	7.19e-05	0.000551	CbGpPWpGaD
Ropinirole—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.09e-05	0.000543	CbGpPWpGaD
Ropinirole—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.94e-05	0.000532	CbGpPWpGaD
Ropinirole—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.85e-05	0.000525	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.84e-05	0.000524	CbGpPWpGaD
Ropinirole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	6.81e-05	0.000522	CbGpPWpGaD
Ropinirole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.77e-05	0.000519	CbGpPWpGaD
Ropinirole—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.77e-05	0.000519	CbGpPWpGaD
Ropinirole—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.64e-05	0.000509	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.64e-05	0.000509	CbGpPWpGaD
Ropinirole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	6.62e-05	0.000507	CbGpPWpGaD
Ropinirole—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.6e-05	0.000506	CbGpPWpGaD
Ropinirole—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.57e-05	0.000503	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.53e-05	0.0005	CbGpPWpGaD
Ropinirole—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.41e-05	0.000491	CbGpPWpGaD
Ropinirole—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.41e-05	0.000491	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.39e-05	0.000489	CbGpPWpGaD
Ropinirole—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.39e-05	0.000489	CbGpPWpGaD
Ropinirole—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.38e-05	0.000488	CbGpPWpGaD
Ropinirole—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.38e-05	0.000488	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.34e-05	0.000486	CbGpPWpGaD
Ropinirole—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.3e-05	0.000483	CbGpPWpGaD
Ropinirole—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.2e-05	0.000475	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.2e-05	0.000475	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.19e-05	0.000474	CbGpPWpGaD
Ropinirole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.16e-05	0.000472	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	6.13e-05	0.000469	CbGpPWpGaD
Ropinirole—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.97e-05	0.000457	CbGpPWpGaD
Ropinirole—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.94e-05	0.000455	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.93e-05	0.000454	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.91e-05	0.000452	CbGpPWpGaD
Ropinirole—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.8e-05	0.000444	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.78e-05	0.000443	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.76e-05	0.000441	CbGpPWpGaD
Ropinirole—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.7e-05	0.000437	CbGpPWpGaD
Ropinirole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.69e-05	0.000436	CbGpPWpGaD
Ropinirole—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.63e-05	0.000431	CbGpPWpGaD
Ropinirole—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.63e-05	0.000431	CbGpPWpGaD
Ropinirole—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.61e-05	0.000429	CbGpPWpGaD
Ropinirole—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.54e-05	0.000424	CbGpPWpGaD
Ropinirole—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.49e-05	0.000421	CbGpPWpGaD
Ropinirole—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.49e-05	0.000421	CbGpPWpGaD
Ropinirole—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.46e-05	0.000418	CbGpPWpGaD
Ropinirole—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.4e-05	0.000414	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.36e-05	0.000411	CbGpPWpGaD
Ropinirole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.31e-05	0.000407	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.19e-05	0.000397	CbGpPWpGaD
Ropinirole—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.16e-05	0.000395	CbGpPWpGaD
Ropinirole—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.16e-05	0.000395	CbGpPWpGaD
Ropinirole—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.04e-05	0.000386	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.04e-05	0.000386	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5e-05	0.000383	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.98e-05	0.000381	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.9e-05	0.000375	CbGpPWpGaD
Ropinirole—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.86e-05	0.000373	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.86e-05	0.000372	CbGpPWpGaD
Ropinirole—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.82e-05	0.000369	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.82e-05	0.000369	CbGpPWpGaD
Ropinirole—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.8e-05	0.000368	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.76e-05	0.000364	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.69e-05	0.000359	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.6e-05	0.000352	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.54e-05	0.000348	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.52e-05	0.000347	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.47e-05	0.000342	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.45e-05	0.000341	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.43e-05	0.000339	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.41e-05	0.000338	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.38e-05	0.000335	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.36e-05	0.000334	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.34e-05	0.000332	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.33e-05	0.000332	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.32e-05	0.000331	CbGpPWpGaD
Ropinirole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.32e-05	0.000331	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.21e-05	0.000323	CbGpPWpGaD
Ropinirole—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.18e-05	0.00032	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.18e-05	0.00032	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.16e-05	0.000319	CbGpPWpGaD
Ropinirole—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.16e-05	0.000319	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.16e-05	0.000318	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.14e-05	0.000317	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.11e-05	0.000315	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.06e-05	0.000311	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.05e-05	0.00031	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.02e-05	0.000308	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.96e-05	0.000303	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.94e-05	0.000302	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.92e-05	0.000301	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.87e-05	0.000297	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.87e-05	0.000296	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.83e-05	0.000293	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.78e-05	0.000289	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.77e-05	0.000289	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.76e-05	0.000288	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.75e-05	0.000287	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.73e-05	0.000286	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.71e-05	0.000284	CbGpPWpGaD
Ropinirole—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.67e-05	0.000281	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.62e-05	0.000277	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.61e-05	0.000277	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.6e-05	0.000276	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.56e-05	0.000273	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.52e-05	0.000269	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.51e-05	0.000269	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.51e-05	0.000268	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.5e-05	0.000268	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.5e-05	0.000268	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.41e-05	0.000261	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.4e-05	0.00026	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.39e-05	0.00026	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.37e-05	0.000258	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.37e-05	0.000258	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.36e-05	0.000257	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.29e-05	0.000252	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.29e-05	0.000252	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.28e-05	0.000251	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.28e-05	0.000251	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.27e-05	0.000251	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.27e-05	0.00025	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	3.24e-05	0.000248	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.22e-05	0.000247	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.18e-05	0.000244	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.18e-05	0.000244	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.17e-05	0.000243	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.17e-05	0.000243	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.17e-05	0.000243	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.13e-05	0.00024	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.1e-05	0.000238	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.06e-05	0.000235	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.05e-05	0.000234	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.05e-05	0.000234	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.98e-05	0.000228	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.97e-05	0.000227	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.93e-05	0.000225	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.93e-05	0.000224	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.92e-05	0.000223	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.91e-05	0.000223	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.89e-05	0.000221	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.88e-05	0.00022	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.85e-05	0.000218	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.84e-05	0.000218	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.82e-05	0.000216	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.77e-05	0.000212	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.75e-05	0.000211	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2.75e-05	0.00021	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.71e-05	0.000208	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.68e-05	0.000206	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.66e-05	0.000204	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.65e-05	0.000203	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.65e-05	0.000203	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.65e-05	0.000203	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.63e-05	0.000201	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.61e-05	0.0002	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.59e-05	0.000198	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.59e-05	0.000198	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.55e-05	0.000195	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.5e-05	0.000191	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.47e-05	0.000189	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.46e-05	0.000189	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.45e-05	0.000188	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.43e-05	0.000186	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.41e-05	0.000184	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.4e-05	0.000184	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.38e-05	0.000182	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.36e-05	0.000181	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.35e-05	0.00018	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.34e-05	0.000179	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.33e-05	0.000178	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000175	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.26e-05	0.000173	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.23e-05	0.000171	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.23e-05	0.000171	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.22e-05	0.00017	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.22e-05	0.00017	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.15e-05	0.000164	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.14e-05	0.000164	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.12e-05	0.000162	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.000161	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.08e-05	0.000159	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000159	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000159	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.07e-05	0.000159	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.01e-05	0.000154	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2e-05	0.000153	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.99e-05	0.000153	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.94e-05	0.000149	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.94e-05	0.000148	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.93e-05	0.000148	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.88e-05	0.000144	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.88e-05	0.000144	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.88e-05	0.000144	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.86e-05	0.000142	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.81e-05	0.000139	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.8e-05	0.000138	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.76e-05	0.000135	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.75e-05	0.000134	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.73e-05	0.000132	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.71e-05	0.000131	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.7e-05	0.00013	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.69e-05	0.000129	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.68e-05	0.000129	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000127	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.64e-05	0.000125	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.57e-05	0.000121	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.56e-05	0.00012	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.00012	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.53e-05	0.000117	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.47e-05	0.000113	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.45e-05	0.000111	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.42e-05	0.000109	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.31e-05	0.000101	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.27e-05	9.71e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.26e-05	9.66e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.23e-05	9.4e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.11e-05	8.53e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.97e-06	7.63e-05	CbGpPWpGaD
